These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 19486452)

  • 41. Randomized controlled trial: roxatidine vs omeprazole for non-erosive reflux disease.
    Nakamura K; Akiho H; Ochiai T; Motomura Y; Higuchi N; Okamoto R; Matsui N; Yasuda D; Akahoshi K; Kabemura T; Ihara E; Harada N; Ito T; Takayanagi R
    Hepatogastroenterology; 2010; 57(99-100):497-500. PubMed ID: 20698216
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Intragastric pH with oral vs intravenous bolus plus infusion proton-pump inhibitor therapy in patients with bleeding ulcers.
    Laine L; Shah A; Bemanian S
    Gastroenterology; 2008 Jun; 134(7):1836-41. PubMed ID: 18423628
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Early effects of oral administration of omeprazole and roxatidine on intragastric pH.
    Iida H; Kato S; Sekino Y; Sakai E; Uchiyama T; Endo H; Hosono K; Sakamoto Y; Fujita K; Yoneda M; Koide T; Takahashi H; Tokoro C; Goto A; Abe Y; Kobayashi N; Kubota K; Gotoh E; Maeda S; Nakajima A; Inamori M
    J Zhejiang Univ Sci B; 2012 Jan; 13(1):29-34. PubMed ID: 22205617
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A new-generation H2 receptor antagonist: quicker and stronger acid inhibition than proton pump inhibitors in the clinical setting?
    Tsuji S; Kawano S
    J Gastroenterol; 2005 May; 40(5):549-50. PubMed ID: 15942726
    [No Abstract]   [Full Text] [Related]  

  • 45. [Diagnosis and therapy of gastroesophageal reflux disease with lansoprazole].
    Bordin DS; Masharova AA
    Eksp Klin Gastroenterol; 2008; (5):85-90. PubMed ID: 19145922
    [No Abstract]   [Full Text] [Related]  

  • 46. The pharmacodynamics and pharmacokinetics of multiple doses of the new H2-receptor antagonist, roxatidine acetate, in healthy men.
    Lassman HB; Ho I; Puri SK; Sabo R; Scheffler MR
    Drugs; 1988; 35 Suppl 3():53-64. PubMed ID: 2905250
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Safety and efficacy of roxatidine acetate. Evidence from pharmacodynamic and clinical trials.
    Merki HS; Bender W; Labs R
    J Clin Gastroenterol; 1989; 11 Suppl 1():S20-3; discussion S24. PubMed ID: 2572621
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Preanaesthetic H2 antagonists for acid aspiration pneumonia prophylaxis. Is there evidence of tolerance?
    Hirota K; Kushikata T
    Br J Anaesth; 2003 May; 90(5):576-9. PubMed ID: 12697583
    [No Abstract]   [Full Text] [Related]  

  • 49. Effects of roxatidine acetate on 24-hour gastric acidity. Early evening versus bedtime administration in healthy subjects.
    Hemery P; Congard P; Galmiche JP; Bonfils S
    Drugs; 1988; 35 Suppl 3():76-81. PubMed ID: 2905253
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [The effect of preoperative oral fluid intake on the volume and pH of gastric contents in elective surgical patients--a comparison of tea with apple juice].
    Tanabe T; Hashimoto Y; Sugihara K; Miyata A; Maeda A; Ishihara H; Matsuki A
    Masui; 1996 Aug; 45(8):967-70. PubMed ID: 8818093
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [A gastric proton pump inhibitor as preanesthetic medication].
    Murakawa T; Kudo A; Kubota T; Hashimoto Y; Takagi Y; Taguchi S; Matsuki A
    Masui; 1994 Mar; 43(3):369-73. PubMed ID: 8182882
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Characteristics of the Human Upper Gastrointestinal Contents in the Fasted State Under Hypo- and A-chlorhydric Gastric Conditions Under Conditions of Typical Drug - Drug Interaction Studies.
    Litou C; Vertzoni M; Goumas C; Vasdekis V; Xu W; Kesisoglou F; Reppas C
    Pharm Res; 2016 Jun; 33(6):1399-412. PubMed ID: 26975361
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Plasma pharmacokinetics of roxatidine in the healthy man: correlation with gastric antisecretory effect].
    Chen WW; Kolsky H; Lewin MJ; Bonfils S
    Gastroenterol Clin Biol; 1990; 14(4):342-6. PubMed ID: 1972124
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Sodium citrate: an alternative antacid for prophylaxis against aspiration pneumonitis.
    Wrobel J; Koh TC; Saunders JM
    Anaesth Intensive Care; 1982 May; 10(2):116-9. PubMed ID: 7103039
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [The effects of preoperative drinking and H2 blocker on gastric acid secretion].
    Suzuki A; Kumano H; Osaka S; Shiomi Y; Moroi K; Ishimura N; Nishiwada M
    Masui; 1996 Apr; 45(4):445-8. PubMed ID: 8725599
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The efficacy and optimum time of administration of ranitidine in the prevention of the acid aspiration syndrome.
    Escolano F; Sierra P; Ortiz JC; Cabrera JC; Castaño J
    Anaesthesia; 1996 Feb; 51(2):182-4. PubMed ID: 8779379
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A comparison of roxatidine acetate 150 mg once daily and 75 mg twice daily in gastric ulcer healing.
    Rösch W
    Drugs; 1988; 35 Suppl 3():127-33. PubMed ID: 2905241
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pharmacologic reduction of the risk of aspiration.
    Gipson SL; Stovall TG; Elkins TE; Crumrine RS
    South Med J; 1986 Nov; 79(11):1356-8. PubMed ID: 3535100
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Omeprazole for prophylaxis of acid aspiration in elective surgery.
    Ng Wingtin L; Glomaud D; Hardy F; Phil S
    Anaesthesia; 1990 Jun; 45(6):436-8. PubMed ID: 2382800
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Effects of different dosages of roxatidine on 24 hrs intragastric pH].
    Kihira K; Yoshida Y; Kasano T; Hirose M; Sato K; Hashimoto M; Kimura K
    Nihon Naika Gakkai Zasshi; 1989 Jul; 78(7):968-9. PubMed ID: 2571653
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.